The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 84.20
Bid: 84.00
Ask: 84.80
Change: 1.20 (1.45%)
Spread: 0.80 (0.952%)
Open: 83.60
High: 84.40
Low: 82.00
Prev. Close: 83.00
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AMP8 Water Framework Win with NWG & Trading Update

10 Jan 2024 07:00

RNS Number : 1624Z
Costain Group PLC
10 January 2024
 

 

Costain Group PLC

10 January 2024

Costain AMP8 Framework Agreement with Northumbrian Water Group and Trading Update

Appointment adds to Costain's wins in the new water regulatory cycle

 

Costain Group PLC ("Costain", or the "Company") announces that it has been appointed by Northumbrian Water Group (NWG) to shape, create and deliver its strategic infrastructure upgrade programme. The framework will see contracts awarded with a potential value of up to £670m to Costain during a 12-year period and builds on recent significant wins in the water sector for the Company.

The framework contract will see Costain work with NWG and its partners to shape, create and deliver solutions to meet the strategic needs of its business plan during Asset Management Period 8 (AMP8). The contract starts immediately and will run for a seven-year initial term with an option for a five-year extension.

The work will involve:

· The design, construction and commissioning of new water and wastewater treatment assets, asset renewals, asset modifications, refurbishments and extensions to treatment works.

· Programmes of investigation and delivery work by asset type, geography and/or by specialism.

AMP8 will see the biggest investment in the water industry for decades. In 2023, Costain extended into AMP8 its Managed Service Provider contract with United Utilities and its consultancy work with Yorkshire Water. Costain has also won funding from Ofwat to support innovation projects.

Trading Update

Costain has had a positive trading year in 2023 and expects to deliver adjusted operating profit in line with market expectations. As a result, and reflecting an increase in financial income compared to 2022 and strong working capital management, together with the accumulation of £25.0m of positive working capital timings, Costain has ended 2023 with a net cash position of £164.4m (2022 year-end: £123.8m), significantly higher than market expectations of £128.6m.

Alex Vaughan, CEO, Costain said:

"Costain is a leading business partner to the water industry, ensuring that water companies achieve value for money as they meet the needs of their customers and the regulator during this crucial period for water investment. We are looking forward to supporting Northumbrian Water in this new working relationship, upgrading both its wastewater and water treatment infrastructure to improve people's lives and safeguard the environment. At Costain, we develop solutions by building collaborative and sustainable relationships with our customers, and we are excited to begin this vital work.

"This contract win not only reflects our continued growth in the water sector, but it also reinforces our commitment to improving critical infrastructure in the North-East of England. This includes major upgrades to the region's highways and our carbon capture work in Teesside as part of the East Coast Cluster, generating opportunities for regional suppliers and employment for local people.

"We are also pleased to report that we have had a positive trading year and expect to deliver adjusted operating profit in line with market expectations. Our cash performance has been very strong, driven by continued improved operational performance, an increase in financial income compared to 2022, and ongoing positive working capital timings."

 

Costain will issue its results for the financial year 2023 on 12 March 2024.

Enquiries:

 

Investors and analysts paul.sharma@costain.com

Paul Sharma, Costain +44 (0) 7867 501188

 

Financial media - Headland costain@headlandconsultancy.com

Andy Rivett-Carnac +44 (0) 7968 997 365

Charlie Twigg +44 (0) 7946 494 568

 

Notes to editors

 

Costain helps to improve people's lives by creating connected, sustainable infrastructure that enables people and the planet to thrive. We shape, create and deliver pioneering solutions that transform the performance of the infrastructure ecosystem across the UK's transport, energy, water, and defence markets.

 

We are organised around our customers anticipating and solving their challenges and helping to improve performance. By bringing together our unique mix of construction, consulting and digital experts we engineer and deliver sustainable, efficient and practical solutions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGGMRLFGDZM
Date   Source Headline
16th Nov 20157:00 amRNSRe: Directorate
11th Nov 20159:56 amRNSBlocklisting Interim Review
30th Oct 201510:01 amRNSTotal Voting Rights
29th Oct 20159:42 amRNSHolding(s) in Company
20th Oct 20151:03 pmRNS2015 Interim Dividend - Scrip Alternative
28th Sep 201511:09 amRNSDirector/PDMR Shareholding
25th Sep 201511:34 amRNSHolding(s) in Company
24th Sep 201510:35 amRNSScrip Dividend Reference Price
15th Sep 20152:45 pmRNSTransfer of Shares
14th Sep 201511:22 amRNSHolding(s) in Company
11th Sep 201510:18 amRNSBoard Change
11th Sep 201510:12 amRNSHolding(s) in Company
24th Aug 20157:06 amRNSRe Contract
20th Aug 20157:00 amRNSHalf Yearly Report
17th Aug 20157:00 amRNSAcquisition
28th Jul 20159:33 amRNSNED Appointment
22nd Jul 20157:00 amRNSRe Contract
22nd Jul 20157:00 amRNSCompletion of Reorganisation of JV in Spain
1st Jul 20159:58 amRNSBlocklisting Interim Review
1st Jul 20157:00 amRNSChanges to JV in Spain
25th Jun 20157:00 amRNSTrading Update
5th Jun 20157:00 amRNSBusiness Briefing
3rd Jun 20157:00 amRNSRe Contract
29th May 20159:17 amRNSTotal Voting Rights and Capital
19th May 201510:24 amRNSDividend - Scrip Alternative
12th May 201510:34 amRNSDirector/PDMR Shareholding
8th May 20154:23 pmRNSLTIP - Blocklisting Application - Correction
7th May 201511:11 amRNSLong Term Incentive Plan - Listing Application
6th May 201511:49 amRNSResult of AGM
6th May 20157:01 amRNSAnnual General Meeting and Financial Calendar
30th Apr 20158:59 amRNSTotal Voting Rights and Capital
23rd Apr 20152:33 pmRNSScrip Dividend Reference Price
8th Apr 201512:25 pmRNSDirector/PDMR Shareholding
31st Mar 201511:16 amRNSTotal Voting Rights
23rd Mar 20157:00 amRNSRe Contract
20th Mar 20157:00 amRNSNotice of AGM and Annual Report and Accounts
17th Mar 201510:18 amRNSHolding(s) in Company
10th Mar 201510:11 amRNSDirector/PDMR Shareholding
3rd Mar 20152:39 pmRNSDividend Declaration
3rd Mar 20157:00 amRNSFinal Results
27th Feb 20159:00 amRNSTotal Voting Rights
30th Jan 20159:00 amRNSTotal Voting Rights
7th Jan 20157:00 amRNSTrading Update
2nd Jan 20157:00 amRNSBlocklisting Interim Review
2nd Jan 20157:00 amRNSTotal Voting Rights
18th Dec 201412:56 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSHolding(s) in Company
1st Dec 20149:00 amRNSTotal Voting Rights
17th Nov 20147:00 amRNSRe Contract
14th Nov 20149:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.